Clinical trials
Phase 4 Agnosia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 9 |
| Not yet recruiting | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University First Hospital | 4 |
| Nanjing Medical University | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Peking Union Medical College Hospital | 2 |
| Weifeng Tu | 2 |
| Capital Medical University | 1 |
| Children's Hospital of Fudan University | 1 |
| China International Neuroscience Institution | 1 |
| Chinese PLA General Hospital | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agnosia | 34 |
| Postoperative Pain | 9 |
| Pain | 3 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Acute Pain | 1 |
| Anxiety Disorders | 1 |
| Breast Neoplasms | 1 |
| Cholelithiasis | 1 |
| Congenital Microtia | 1 |
| Delirium | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.